ALISON HAFFNER: Open Payments
NPI 1952814113 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$631 in 13 payments from 10 companies in 2025. Trend: 2023 $1,621 · 2024 $1,016 · 2025 $631
Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $148 |
| Janssen Biotech, Inc. | 1 | $124 |
| Astellas Pharma US Inc | 1 | $121 |
| Genentech USA, Inc. | 4 | $112 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| JAZZ PHARMACEUTICALS INC. | 1 | $19 |
| PFIZER INC. | 1 | $14 |
Products named: RYBREVANT, Padcev, Polivy, Venclexta, OJJAARA, Itovebi, VERZENIO, LIBTAYO.
Industry payments across IN — which companies pay providers there.
